Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dual antiplatelet therapy versus triple therapy after coronary stenting in low-risk atrial fibrillation
2009-017256-27Phase 4Active
- Sponsor
- Vall d'Hebron University Hospital
- Start
- Dec 2009
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of acenocoumarol, clopidogrel and aspirin in Atrial fibrillation (AFib) and coronary arteriosclerosis (2 arms), sponsored by Vall d'Hebron University Hospital. Primary endpoint: Primary composite efficacy and safety endpoint. Started Dec 2009; status: active.
02
Drugs
acenocoumarolclopidogrelaspirin
03
Conditions
Atrial fibrillation (AFib)coronary arteriosclerosis
Beyond the preview
Go deeper on 2009-017256-27.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-017256-27.